Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: jackie who wrote (9624)	4/14/1999 1:31:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Saunders NJ, Cohen J. A study of the interaction between recombinant bactericidal permeability increasing protein (rBPI23) and gentamicin. International Journal of Antimicrobial Agents 1995; 5: 259-263. Seelen MA, Athanassiou P, Lynn WA, Norsworthy P, Walport MJ, Cohen J, Davies KA. The anti-lipid A monoclonal antibody E5 binds to rough Gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes. Immunology 1995; 84: 653-661.